Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Geron Corporation - Common Stock
(NQ:
GERN
)
1.410
+0.010 (+0.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Geron Corporation - Common Stock
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Geron Corporation Reports Third Quarter 2022 Financial Results and Upcoming Expected Milestones
November 03, 2022
From
Geron Corporation
Via
Business Wire
Earnings Preview: Geron
↗
November 02, 2022
Geron (NASDAQ:GERN) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Geron will report an...
Via
Benzinga
10 Best Medical Stocks Under $5
↗
October 29, 2022
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the...
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
↗
October 28, 2022
Upgrades
Via
Benzinga
Recap: Geron Q2 Earnings
↗
August 11, 2022
Geron (NASDAQ:GERN) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Geron to Announce Third Quarter 2022 Financial Results on November 3, 2022
October 27, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 20, 2022
From
Geron Corporation
Via
Business Wire
Marathon Digital, Coinbase Global And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
↗
September 27, 2022
U.S. stock futures traded higher this morning after recording losses in the previous session. Here are some big stocks moving higher in today’s pre-market trading session.
Via
Benzinga
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket
↗
September 27, 2022
Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for...
Via
Benzinga
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 22, 2022
From
Geron Corporation
Via
Business Wire
H.B. Fuller, Lennar And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
↗
September 22, 2022
U.S. stock futures traded slightly higher this morning after recording losses in the previous session. Here are some big stocks moving higher in today’s pre-market trading session.
Via
Benzinga
7 Top-Rated Biotech Stocks to Buy for Q4
↗
September 15, 2022
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
↗
September 13, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors
September 08, 2022
From
Geron Corporation
Via
Business Wire
Geron's Return On Capital Employed Insights
↗
September 06, 2022
According to data from Benzinga Pro, during Q2, Geron's (NASDAQ:GERN) reported sales totaled $73 thousand. Despite a 6.58% increase in earnings, the company posted a loss of $28.12 million.
Via
Benzinga
Geron to Present at Upcoming Investor Conferences
September 01, 2022
From
Geron Corporation
Via
Business Wire
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
↗
August 22, 2022
Via
Benzinga
Geron Commences Initial-Stage Rare Blood Cancer Combination Study
↗
August 22, 2022
Geron Corporation (NASDAQ: GERN) has dosed first patient in IMproveMF study evaluating imetelstat in combination with ruxolitinib for patients with frontline myelofibrosis (MF).
Via
Benzinga
Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis
August 22, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2022
From
Geron Corporation
Via
Business Wire
Cowen Slashes Price Target On This Stock By Over 78%; Also Check Out Some Other Big PT Changes
↗
August 12, 2022
Cowen & Co. cut the price target for The RealReal, Inc. (NASDAQ: REAL) from $14 to $3. RealReal shares fell 0.7% to $3.1388 in pre-market trading.
Via
Benzinga
Geron Corporation Reports Second Quarter 2022 Financial Results
August 11, 2022
From
Geron Corporation
Via
Business Wire
Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022
August 04, 2022
From
Geron Corporation
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
August 04, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference
August 03, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 21, 2022
From
Geron Corporation
Via
Business Wire
7 Best Penny Stocks Under $3 to Buy in July
↗
July 13, 2022
If you think the volatility in the broader indices isn’t enough excitement, here are the best penny stocks to consider under $3.
Via
InvestorPlace
Geron Corporation Announces Expansion of Existing Loan Facility
June 30, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 16, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces Appointment of Faye Feller, M.D. to Chief Medical Officer and Transition of Aleksandra Rizo, M.D., Ph.D. to Senior Advisor Role
June 15, 2022
From
Geron Corporation
Via
Business Wire
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit